Renaissance Technologies’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.28M Sell
10,836
-74,250
-87% -$22.5M ﹤0.01% 1782
2025
Q1
$28.2M Sell
85,086
-75,696
-47% -$25.1M 0.04% 523
2024
Q4
$49.6M Buy
160,782
+116,285
+261% +$35.9M 0.07% 327
2024
Q3
$9.44M Buy
+44,497
New +$9.44M 0.01% 1074
2023
Q4
Sell
-68,082
Closed -$9.94M 3969
2023
Q3
$9.94M Sell
68,082
-10,600
-13% -$1.55M 0.02% 922
2023
Q2
$18.2M Sell
78,682
-96,700
-55% -$22.3M 0.03% 722
2023
Q1
$42.5M Buy
175,382
+170,800
+3,728% +$41.4M 0.06% 396
2022
Q4
$1.33M Buy
+4,582
New +$1.33M ﹤0.01% 2355
2022
Q2
Sell
-4,800
Closed -$471K 4439
2022
Q1
$471K Buy
4,800
+2,400
+100% +$236K ﹤0.01% 3234
2021
Q4
$203K Sell
2,400
-14,711
-86% -$1.24M ﹤0.01% 3505
2021
Q3
$1.37M Sell
17,111
-35,871
-68% -$2.86M ﹤0.01% 2376
2021
Q2
$5.16M Buy
52,982
+18,700
+55% +$1.82M 0.01% 1614
2021
Q1
$4.01M Buy
34,282
+249
+0.7% +$29.1K 0.01% 1794
2020
Q4
$3.78M Buy
34,033
+12,251
+56% +$1.36M ﹤0.01% 1759
2020
Q3
$2.59M Sell
21,782
-50,600
-70% -$6.01M ﹤0.01% 1979
2020
Q2
$8.2M Buy
72,382
+45,900
+173% +$5.2M 0.01% 1343
2020
Q1
$1.77M Buy
+26,482
New +$1.77M ﹤0.01% 2114
2018
Q1
Sell
-87,587
Closed -$8.04M 3485
2017
Q4
$8.04M Sell
87,587
-39,700
-31% -$3.64M 0.01% 1513
2017
Q3
$5.73M Buy
127,287
+51,900
+69% +$2.33M 0.01% 1688
2017
Q2
$1.23M Buy
75,387
+17,512
+30% +$285K ﹤0.01% 2496
2017
Q1
$891K Buy
57,875
+400
+0.7% +$6.16K ﹤0.01% 2580
2016
Q4
$856K Buy
57,475
+4,488
+8% +$66.8K ﹤0.01% 2607
2016
Q3
$672K Sell
52,987
-3,187
-6% -$40.4K ﹤0.01% 2723
2016
Q2
$512K Sell
56,174
-10,483
-16% -$95.5K ﹤0.01% 2791
2016
Q1
$560K Sell
66,657
-4,892
-7% -$41.1K ﹤0.01% 2815
2015
Q4
$881K Buy
+71,549
New +$881K ﹤0.01% 2519
2015
Q2
Sell
-18,763
Closed -$1.27M 3303
2015
Q1
$1.27M Buy
18,763
+489
+3% +$33.2K ﹤0.01% 2179
2014
Q4
$1.7M Buy
18,274
+7,495
+70% +$695K ﹤0.01% 1890
2014
Q3
$1.14M Buy
+10,779
New +$1.14M ﹤0.01% 1963
2014
Q1
Sell
-6,114
Closed -$1.12M 2942
2013
Q4
$1.12M Buy
+6,114
New +$1.12M ﹤0.01% 2022